Advertisement

908 Devices Inc. MASS

Set alert

Price alert · MASS

All alert types
11.25 USD -1.60 -12.45%

At close · Oct 30

11.24 -0.01 -0.08%

After hours · Oct 30, 4:56 PM ET

Bid
11.22 × 2
Ask
11.25 × 2
10.92 Day range 12.60
5.03 52-week range 13.35
YTD
+114.29%
1 year
+47.44%
Open
12.44
Prev close
12.85
Mkt cap
465.00M
Vol
551.09K
Avg vol
424.19K
EPS
-0.94
P/E
0.00
Div yield
0.00%
More statistics
Low
10.92
High
12.60
Forward P/E
-1.78
Beta
0.98
Short ratio
3.57
Inst. own
69.75%
Dividend
0.00
Ex-div date
Earnings
Aug 6, 2024
50-d avg
2.87
200-d avg
4.69
1y target
5.67

3M chart

Chart tools
Interval

Signals (18)
NameDateAgo
SMA: BearishOct 30, 20262 days ago
MACD: Sell SignalOct 30, 20262 days ago
MACD: Buy SignalOct 28, 20264 days ago
SMA: BullishOct 26, 20266 days ago
SMA: BearishOct 22, 20261 week ago
MACD: Sell SignalOct 8, 20263 weeks ago
RSI: OverboughtSep 30, 20261 month ago
MACD: Buy SignalSep 21, 20261 month ago
SMA: BullishSep 17, 20261 month ago
SMA: BearishSep 16, 20261 month ago
SMA: BullishSep 15, 20261 month ago
SMA: BearishSep 9, 20261 month ago
MACD: Sell SignalSep 1, 20262 months ago
RSI: OverboughtAug 27, 20262 months ago
RSI: OverboughtAug 11, 20262 months ago
SMA: BullishAug 3, 20263 months ago
SMA: BullishAug 3, 20263 months ago
MACD: Buy SignalJul 31, 20263 months ago

Key statistics

Market cap
66.16M
Enterprise value
7.23M
Trailing P/E
0.00
Forward P/E
-1.78
PEG ratio
0.00
Price / sales
1.20
Price / book
0.50
EPS (TTM)
-1.79
Beta
0.98
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-109.11%
Revenue (TTM)
55.16M
Revenue growth
17.30%
Free cash flow
-18.16M
Total cash
71.69M
Total debt
7.18M
Return on equity
-40.00%
Shares outstanding
34.82M
Short % of float
6.31%
50-day average
2.87
200-day average
4.69

Analyst view

Consensus: none

Price target (mean) 5.67 -49.6% downside
Target (low)
4.00
Target (mean)
5.67
Target (high)
7.00
Ratings (0m) 5 4 buy · 1 hold · 0 sell
  • Strong buy0
  • Buy4
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Aug 6, 2024

Expected Aug 6, 2024. Consensus EPS estimate -0.365.

Earnings history

Financials — quick view

All financials
MASS Revenue — quarterly 16.07M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
MASS Net income — quarterly -11.89M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
MASS EPS — quarterly -0.32
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

MASS recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 12, 2024Sep 1, 2024-0.29-0.23+0.06+20.69%
Aug 6, 2024Jun 1, 2024-0.34-0.32+0.02+5.88%
Aug 6, 2024Jun 1, 2024-0.34———
Apr 30, 2024Mar 1, 2024-0.37-0.33+0.04+10.81%
Apr 30, 2024Mar 1, 2024-0.37———
Mar 5, 2024Dec 1, 2023-0.27———

Upgrades / downgrades

MASS analyst upgrades and downgrades
DateFirmActionFromTo
Nov 13, 2024StifelmainBuyBuy
Nov 13, 2024Leerink PartnersdownOutperformMarket Perform
Oct 17, 2024Leerink PartnersmainOutperformOutperform
May 13, 2024Stephens & Co.reitOverweightOverweight
Sep 25, 2023Stephens & Co.reitOverweightOverweight
Feb 7, 2023Stephens & Co.init—Overweight

About 908 Devices Inc.

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on MASS — it syncs with the Stock Master app.

Insider holders

MASS insider holders
InsiderRelationLatest transactionDateShares held
BROWN CHRISTOPHER DOfficerConversion of Exercise of derivative securityDec 18, 2024946,453
CRANDELL KEITH L.Director and Beneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityJun 11, 20245,738,970
EISENBERG MARCIADirectorConversion of Exercise of derivative securityJun 11, 202414,593
ELOI FENEL MDirectorConversion of Exercise of derivative securityJun 11, 202415,450
GEORGE JEFFREY P.DirectorConversion of Exercise of derivative securityJun 11, 202415,450
GRIFFITH JOSEPH H. IVChief Financial OfficerConversion of Exercise of derivative securityMar 25, 202493,437

Institution ownership

MASS institution ownership
Holder% heldSharesValueReported
ARK Investment Management, LLC9.25%3,219,5496.12MSep 29, 2024
Blackrock Inc.5.41%1,884,4803.58MSep 29, 2024
Vanguard Group Inc5.39%1,877,6963.57MSep 29, 2024
Ameriprise Financial, Inc.5.29%1,842,8463.50MSep 29, 2024
AWM Investment Company, Inc.4.52%1,574,3302.99MSep 29, 2024
Granahan Investment Management LLC2.47%861,4331.64MSep 29, 2024

Fund ownership

MASS fund ownership
Holder% heldSharesValueReported
ARK ETF Tr-ARK Genomic Revolution ETF8.97%3,125,2575.94MOct 30, 2024
Columbia Fds Ser Tr I-Columbia Small Cap Growth Fd I4.33%1,508,6062.87MAug 30, 2024
Vanguard Total Stock Market Index Fund2.27%792,1571.51MSep 29, 2024
iShares Russell 2000 ETF1.78%618,8151.18MOct 30, 2024
Vanguard Information Technology Index Fund1.74%605,9831.15MAug 30, 2024
Alger Fund-Small Cap Growth Fund1.28%444,981845.46KJul 30, 2024
Advertisement